精神分裂症中MAP2差异磷酸化改变其功能
该研究探讨精神分裂症中微管相关蛋白2(MAP2)磷酸化改变及其功能后果。采用无偏磷酸化蛋白质组学量化18个MAP2磷酸肽,发现9个在精神分裂症中显著改变;磷酸化模拟小鼠S1782E显示树突长度和复杂性降低、树突棘密度下降;MAP2互作组富集翻译相关蛋白,过表达野生型和磷酸化模拟MAP2均降低体外蛋白合成。低MAP2免疫反应性的精神分裂症患者突触蛋白水平降低,S1782E小鼠重现此模式,提示“MAP2opathy”概念框架。
要点
- 精神分裂症中9个MAP2磷酸肽显著改变,聚为三个模块分别与树突棘丢失、突触蛋白水平和临床功能相关。
- S1782磷酸化降低MAP2与微管结合,S1782E小鼠表现树突长度和复杂性及树突棘密度降低。
- 低MAP2免疫反应性精神分裂症患者突触蛋白水平降低,S1782E小鼠重现该模式。
核心结论
- 精神分裂症中MAP2磷酸化改变导致神经元结构、突触蛋白合成和功能受损,支持“MAP2opathy”概念框架。
研究设计与样本
- 使用无偏磷酸化蛋白质组学量化精神分裂症受试者MAP2磷酸肽,并结合计算建模、转基因小鼠和共免疫沉淀-质谱分析。
主要发现
- 18个MAP2磷酸肽中9个在精神分裂症受试者中显著改变,网络分析聚为三个模块,各与树突棘丢失、突触蛋白水平和临床功能有不同关系。
- 精神分裂症中最过度磷酸化位点pS1782的计算建模预测磷酸化降低MAP2与微管结合,并经实验证实。
- S1782E磷酸化模拟小鼠基底树突长度和复杂性降低、树突棘密度下降。
- MAP2互作组富集翻译相关蛋白,过表达野生型和磷酸化模拟MAP2均降低体外蛋白合成。
- 低MAP2免疫反应性精神分裂症受试者突触蛋白水平相对于非精神科对照和MAP2免疫反应性正常的精神分裂症受试者降低,S1782E小鼠重现该模式。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Schizophrenia (Sz) is a highly polygenic disorder, with common, rare, and structural variants each contributing only a small fraction of overall disease risk. Thus, there is a need to identify downstream points of convergence that can be targeted with therapeutics. Reduction of microtubule-associated protein 2 (MAP2) immunoreactivity (MAP2-IR) is present in individuals with Sz, despite no change in MAP2 protein levels. MAP2 is phosphorylated downstream of multiple receptors and kinases identified as Sz risk genes, altering its immunoreactivity and function. Using an unbiased phosphoproteomics approach, we quantified 18 MAP2 phosphopeptides, 9 of which were significantly altered in Sz subjects. Network analysis grouped MAP2 phosphopeptides into three modules, each with a distinct relationship to dendritic spine loss, synaptic protein levels, and clinical function in Sz subjects. We then investigated the most hyperphosphorylated site in Sz, phosphoserine1782 (pS1782). Computational modeling predicted phosphorylation of S1782 reduces binding of MAP2 to microtubules, which was confirmed experimentally. We generated a transgenic mouse containing a phosphomimetic mutation at S1782 (S1782E) and found reductions in basilar dendritic length and complexity along with reduced spine density. Because only a limited number of MAP2 interacting proteins have been previously identified, we combined co-immunoprecipitation with mass spectrometry to characterize the MAP2 interactome in mouse brain. The MAP2 interactome was enriched for proteins involved in protein translation. These associations were shown to be functional as overexpression of wild type and phosphomimetic MAP2 reduced protein synthesis in vitro. Finally, we found that Sz subjects with low MAP2-IR had reductions in the levels of synaptic proteins relative to nonpsychiatric control (NPC) subjects and to Sz subjects with normal and MAP2-IR, and this same pattern was recapitulated in S1782E mice. These findings suggest a new conceptual framework for Sz-that a large proportion of individuals have a "MAP2opathy"-in which MAP function is altered by phosphorylation, leading to impairments of neuronal structure, synaptic protein synthesis, and function.
引用
- Grubisha MJ, Sun X, MacDonald ML, et al. MAP2 is differentially phosphorylated in schizophrenia, altering its function. Mol Psychiatry. 2021. PMID: 33526823. doi:10.1038/s41380-021-01034-z
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。